Nektar Therapeutics (NASDAQ:NKTR)

57.36
Delayed Data
As of Jun 19
 -1.05 / -1.80%
Today’s Change
17.51
Today|||52-Week Range
111.36
-3.95%
Year-to-Date

Today’s Trading

Previous close58.41
Today’s open58.00
Day’s range56.11 - 58.29
Volume3,672,143
Average volume (3 months)3,820,630
Market cap$13.9B
Data as of 4:00pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)+43.64%
Earnings growth (this year)+544.01%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+86.00%
P/E ratioNM
Price/Sales30.27
Price/Book147.00

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+6.19+8.07%
----
XONIntrexon Corp+0.53+3.22%
BPMCBlueprint Medicines ...+1.75+2.58%
Data as of 4:02pm ET, 06/19/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$3.91
Annual revenue (last year)$307.7M
Annual profit (last year)-$96.7M
Net profit margin-31.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts